<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-22T07:57:45Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/40EA3FDF-C34E-4397-BDE1-A722DC14AB9E" ns1:id="40EA3FDF-C34E-4397-BDE1-A722DC14AB9E"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/B8935360-61EC-4547-BF16-E2B711B59C83" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/C85457A5-5779-4C1B-AAEF-5F228120745A" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/C85457A5-5779-4C1B-AAEF-5F228120745A" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2016-03-30T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/922C9EE8-C17D-49B7-A926-6BD00F06DDA6" ns1:rel="FUND" ns1:start="2015-12-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">700641</ns2:identifier></ns2:identifiers><ns2:title>Point of Care Testing for Autoimmune Disorders</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>GRD Proof of Market</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Autoimmune diseases result from a dysfunction of the immune system; the body produces an
immune response against its own tissues, and attacks its own organs, tissues, and cells. There
are &amp;gt;80 types of autoimmune disorders, including thyroid and coeliac disease. Nalia have
identified an opportunity to develop a rapid, cost-effective immunoassay which detects
multiple autoimmune biomarkers within 20 mins at the point of care.</ns2:abstractText></ns2:project>